Not recruitingISRCTN75905964
SMaRT Oncology-3: a two-arm parallel group randomised controlled trial to determine the efficacy of adding a complex intervention for major depressive disorder ("Depression Care for People with Lung Cancer") to usual care, compared to usual care alone in patients with lung cancer
Interventional studyAges 18+United KingdomAdjustment disorder
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Edinburgh (UK)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN75905964
- Official title
Show the full official title
SMaRT Oncology-3: a two-arm parallel group randomised controlled trial to determine the efficacy of adding a complex intervention for major depressive disorder ("Depression Care for People with Lung Cancer") to usual care, compared to usual care alone in patients with lung cancer
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Registry details
Registry conditions (original wording)
Depression in patients with cancer; Mental and Behavioural Disorders; Reaction to severe stress and adjustment disorders
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Edinburgh (UK), a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
